New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention

Published:2010-11 Issue:19 Volume:56 Page:1542-1551
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bellemain-Appaix Anne,Brieger David,Beygui Farzin,Silvain Johanne,Pena Ana,Cayla Guillaume,Barthélémy Olivier,Collet Jean-Philippe,Montalescot Gilles

Funder

Sanofi-Aventis

Eli Lilly

Merck/Schering Plough

National Heart Foundation of Australia

Daiichi-Sankyo

INSERM

Fédération Française de Cardiologie

Société Française de Cardiologie

Bristol-Myers Squibb

Guerbet Medical

Medtronic

Boston Scientific

Cordis

Stago

Centocor

Fondation de France

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting;Leon;N Engl J Med,1998

2. Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting

3. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

4. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting;Bhatt;J Am Coll Cardiol,2002

5. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery — From the Melbourne Interventional Group (MIG) registry;Cardiovascular Revascularization Medicine;2023-07

2. Performance of the Academic Research Consortium High Bleeding Risk Criteria in Patients With ST-Segment Elevation Myocardial Infarction: A Single Center Study;Angiology;2022-10-29

3. Newer P2Y12 Inhibitors vs Clopidogrel in Acute Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock: A Systematic Review and Meta-analysis;Mayo Clinic Proceedings;2022-06

4. Comparison of Ticagrelor With Clopidogrel in East Asian Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Journal of Cardiovascular Pharmacology;2022-05

5. Preparation of injectable clopidogrel loaded submicron emulsion for enhancing physicochemical stability and anti-thrombotic efficacy;International Journal of Pharmaceutics;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3